Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 18 studies | 42% ± 18% | |
oligodendrocyte | 15 studies | 65% ± 14% | |
glutamatergic neuron | 12 studies | 68% ± 21% | |
oligodendrocyte precursor cell | 12 studies | 38% ± 13% | |
GABAergic neuron | 11 studies | 58% ± 24% | |
pericyte | 11 studies | 35% ± 17% | |
adipocyte | 7 studies | 26% ± 7% | |
neuron | 6 studies | 51% ± 23% | |
interneuron | 6 studies | 71% ± 13% | |
microglial cell | 5 studies | 37% ± 16% | |
cardiac muscle cell | 5 studies | 35% ± 7% | |
endothelial cell | 4 studies | 53% ± 18% | |
retinal ganglion cell | 4 studies | 69% ± 12% | |
smooth muscle cell | 4 studies | 22% ± 5% | |
GABAergic interneuron | 3 studies | 70% ± 4% | |
granule cell | 3 studies | 37% ± 7% | |
progenitor cell | 3 studies | 41% ± 17% | |
mesothelial cell | 3 studies | 35% ± 15% | |
GABAergic amacrine cell | 3 studies | 52% ± 8% | |
OFF-bipolar cell | 3 studies | 35% ± 7% | |
glycinergic amacrine cell | 3 studies | 19% ± 3% | |
amacrine cell | 3 studies | 50% ± 17% | |
ciliated cell | 3 studies | 21% ± 3% | |
fibroblast | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 706.34 | 2531 / 2642 | 99% | 13.30 | 698 / 705 |
prostate | 92% | 298.02 | 225 / 245 | 100% | 12.71 | 502 / 502 |
breast | 96% | 284.57 | 440 / 459 | 80% | 6.08 | 891 / 1118 |
uterus | 100% | 628.23 | 170 / 170 | 36% | 3.44 | 167 / 459 |
ovary | 100% | 931.75 | 180 / 180 | 33% | 1.38 | 142 / 430 |
stomach | 84% | 276.37 | 300 / 359 | 44% | 1.98 | 125 / 286 |
bladder | 90% | 478.52 | 19 / 21 | 37% | 1.95 | 184 / 504 |
skin | 43% | 135.47 | 778 / 1809 | 82% | 7.64 | 387 / 472 |
kidney | 90% | 253.21 | 80 / 89 | 30% | 1.17 | 269 / 901 |
lung | 65% | 116.15 | 378 / 578 | 41% | 1.71 | 470 / 1155 |
intestine | 79% | 778.29 | 765 / 966 | 24% | 1.09 | 125 / 527 |
adrenal gland | 49% | 83.43 | 126 / 258 | 54% | 3.58 | 124 / 230 |
adipose | 96% | 378.25 | 1161 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 64% | 482.91 | 924 / 1445 | 32% | 1.27 | 58 / 183 |
pancreas | 12% | 16.36 | 38 / 328 | 83% | 4.96 | 148 / 178 |
heart | 81% | 217.89 | 700 / 861 | 0% | 0 | 0 / 0 |
muscle | 73% | 210.47 | 587 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 1.40 | 13 / 29 |
thymus | 21% | 28.44 | 134 / 653 | 16% | 1.86 | 97 / 605 |
blood vessel | 33% | 75.25 | 439 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 22% | 1.19 | 10 / 45 |
liver | 0% | 0 | 0 / 226 | 14% | 0.79 | 55 / 406 |
eye | 0% | 0 | 0 / 0 | 13% | 0.60 | 10 / 80 |
spleen | 2% | 3.02 | 6 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.92 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007624 | Biological process | ultradian rhythm |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0003756 | Molecular function | protein disulfide isomerase activity |
GO_0003954 | Molecular function | NADH dehydrogenase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ENOX1 |
Protein name | Ecto-NOX disulfide-thiol exchanger 1 (Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase) (cCNOX) (Cell proliferation-inducing gene 38 protein) (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)] Ecto-NOX disulfide-thiol exchanger 1 isoform 3 Ecto-NOX disulfide-thiol exchanger 1 isoform 1 |
Synonyms | PIG38 |
Description | FUNCTION: Probably acts as a terminal oxidase of plasma electron transport from cytosolic NAD(P)H via hydroquinones to acceptors at the cell surface. Hydroquinone oxidase activity alternates with a protein disulfide-thiol interchange/oxidoreductase activity which may control physical membrane displacements associated with vesicle budding or cell enlargement. The activities oscillate with a period length of 24 minutes and play a role in control of the ultradian cellular biological clock. . |
Accessions | ENST00000690772.1 [Q8TC92-1] Q8TC92 A0A0S2Z5N4 ENST00000261488.10 [Q8TC92-1] A0A024RDT8 |